J. Horton

Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia

Peter A. Jones, Philip J. Chapman, P. Grandi, 2021, Nature Cancer.

Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor

Brady Bernard, P. Traber, T. Shimada, 2021, Journal for ImmunoTherapy of Cancer.

TU‐C‐AUD‐06: Calculation of the Dose Distribution Around a Commercially Available 125I Brachytherapy Source Via a Multi‐Group Discrete Ordinates Method

F. Mourtada, T. Wareing, K. Gifford, 2007 .

2861 : Ru-106 Eye Plaques for Treatment of Ocular Melanoma - Practical Issues

A. Garden, D. Gombos, F. Mourtada, 2006 .